Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia [Phase 2]
Phase 2 trial updating verinurad and allopurinol in chronic kidney disease with hyperuricemia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients [Phase 4]
A Phase 4 clinical trial is evaluating pharmacokinetics of microdose midazolam and several statins in healthy volunteers and patients with c…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Vitamin D, Oxidative Stress and Inflammation in Hemodialysis [Phase 2, Phase 3]
A clinical trial update on the effects of vitamin D on oxidative stress and inflammation in patients undergoing hemodialysis, with phase 2 a…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Comparative Study Between Oral Liposomal Iron,Iron Supported Lactoferrin and IV Iron Dextran in CKD Children [Phase 4]
A phase 4 comparative trial in children with chronic kidney disease comparing oral liposomal iron, iron-supported lactoferrin, and IV iron d…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Effect of Melatonin in Pediatric Hemodialysis Patients [Phase 3]
A Phase 3 trial evaluating the effect of melatonin in pediatric patients undergoing hemodialysis, focusing on complications, oxidative stres…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Exercise Trial in Chronic Kidney Disease [NA]
A completed clinical trial evaluating exercise intervention in patients with chronic kidney disease; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia [Phase 4]
Phase 4 trial update evaluating the safety and efficacy of Roxadustat for heart failure with chronic kidney disease and anemia.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease [Phase 2]
Phase 2 trial assessing nicotinamide riboside with Co-enzyme Q10 in chronic kidney disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Renal Osteodystrophy: An Individual Management Approach [NA]
A completed clinical trial update discussing an individual management approach to renal osteodystrophy in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Chronic Kidney Disease (CKD) Platelet Study [Phase 3]
Phase 3 clinical trial update for a CKD-related platelet study; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Sodium Lowering and Urinary Protein Reduction Trial [Phase 3]
Phase 3 trial completed evaluating sodium lowering for reducing urinary protein in chronic kidney disease with albuminuria.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease [Phase 2]
Phase 2 trial assessing vascular effects of mineralocorticoid receptor antagonism in chronic kidney disease with albuminuria.
-
CLINICAL_TRIALS trial_result · 2022-12-09Clinical Trial Update: Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency [Phase 4]
Phase 4 trial update evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of CTAP101, immediate-release calcifediol, high-dose…
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) [Phase 2]
This document reports the completion of the MERLIN Phase 2 trial evaluating bardoxolone methyl in patients with chronic kidney disease at ri…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Safe Use of Heparin Sodium in Patients With Chronic Renal Failure. [Phase 2, Phase 3]
Clinical trial update on the safe use of heparin sodium in patients with chronic renal failure; study status is suspended for Phase 2 and Ph…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk [Phase 3]
Phase 3 trial evaluating sotagliflozin in type 2 diabetes with moderate renal impairment at cardiovascular risk; study terminated with poste…
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis [Phase 3]
Phase 3 trial evaluating TRC101 for slowing progression of chronic kidney disease in patients with metabolic acidosis was terminated.
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia [Phase 2]
Phase 2 trial evaluating pharmacodynamics and safety of patiromer in children and adolescents with chronic kidney disease and hyperkalemia; …
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating protective effects of activated charcoal and a probiotic on progression of chronic kidney disease associate…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease [Phase 2]
Phase 2 trial investigating whether oral magnesium can affect vascular calcification in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects [Phase 2, Phase 3]
A Phase 2/3 trial evaluating sodium bicarbonate supplementation in chronic kidney disease for dose-response, safety, and beneficial effects …
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Phosphate Lowering in CKD Trial [Phase 4]
A Phase 4 trial examining phosphate lowering in chronic kidney disease with cardiovascular disease has completed and results were posted in …
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) [Phase 4]
A phase 4 clinical trial assessing the impact of urate-lowering therapy on kidney function in patients with gout and chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ) [Phase 1, Phase 2]
Clinical trial update for human umbilical cord mesenchymal stem cells in chronic kidney disease (stages 3-4) spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD [Phase 4]
Phase 4 clinical trial assessing the acute effects of intravenous iron on oxidative stress and endothelial dysfunction in non-dialysis chron…